HPRA hosts information evening for healthcare professionals on biosimilar medicines

News Category: Regulatory news

Date: 03/11/2017

The HPRA recently hosted a successful information evening for healthcare professionals to outline how biosimilar medicines are approved for use in patients.  

Approximately 60 attendees were present to hear a range of presentations from HPRA staff members and from Dr. Anthony O’Connor who presented from the physician perspective.  
The topics covered by the HPRA team included:

-  An overview of biological and biosimilar medicines;
-  Quality and non-clinical data requirements for biosimilars;
-  Clinical data requirements for biosimilars;
-  Pharmacovigilance;
-  International trends and Interchangeability.

The HPRA slides are now available to view and download from our website.

The event concluded with an interactive Q&A session which incorporated a varied range of queries from attendees. 

« Back